​

Funding Round

Series B - Lu Daopei Medical Group

Series B - Lu Daopei Medical Group

Investment Firm

Overview

Lu Daopei Medical Group is a renowned hematology specialist and pioneer of Chinese bone marrow transplantation.

Announced Date

Jul 22, 2020

Funding Type

Series B

Highlights

Location

Asia

Social

N/A

Investor Lead

Temasek Holdings

Temasek Holdings

Temasek Holdings is a early_stage_venture and late_stage_venture and private_equity and secondary_market firm.

Participant Investors

2

Investor Name
Participant InvestorInvestcorp
Participant InvestorTemasek Holdings

Round Details and Background

Lu Daopei Medical Group raised $71426531 on 2020-07-22 in Series B

Lu Daopei Medical Group is a renowned hematology specialist and pioneer of Chinese bone marrow transplantation.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 22, 2020
Series B - Lu Daopei Medical Group
2-71.4M
Jan 01, 2014
Venture Round - Lu Daopei Medical Group
1-undefined

Recent Activity

There is no recent news or activity for this profile.